![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Yi Jun
Publisher: Springer Publishing Company
ISSN: 1010-4283
Source: Tumor Biology, Vol.32, Iss.1, 2011-02, pp. : 45-51
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Forty years experience of treating cancer of unknown primary
Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gemcitabine and cisplatin in patients with carcinoma of unknown primary site
By Isik Metin
Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Unknown Primary Squamous Cell Carcinoma of the Head and Neck
Current Cancer Therapy Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. :